Archive for the ‘Lyme’ Category

Burrascano Webinar on Borreliosis Testing (Lyme & TBRF)

https://www.lymedisease.org/burrascano-webinar-borreliosis/

Burrascano webinar on borreliosis testing (Lyme and TBRF)

The name “borreliosis” can refer to two distinct but similar infections: Lyme disease and tick-borne relapsing fever (TBRF).

Both diseases result from different subspecies of Borrelia. They exhibit many of the same symptoms and both are spreading geographically.

According to world-renowned Lyme disease specialist Dr. Joseph Burrascano, these diseases present significant challenges to patients and healthcare practitioners alike.

Dr. Burrascano recently presented a webinar with IGeneX, Inc., about testing for both infections. Dr. Jyotsna Shah, president and laboratory director of IGeneX, joined him in the question and answer period.

Read the Latest Documents From Lyme Lawsuit Against IDSA

https://www.lymedisease.org/latest-documents-torrey-lawsuit/

Read the latest documents from Lyme lawsuit against IDSA

From journalist Mary Beth Pfeiffer on Facebook:

“I have posted the latest documents in the Torrey v. IDSA case on my website. As many know, the lawsuit was dismissed in federal court in Texas. More than 400 documents were filed in the case since 2017; I’ve posted the key filings.

“The dismissal will be appealed, I’m told. One good outcome is this: Eight insurance companies chose to settle the case. This development might help others to convince insurance companies that claims for care should be paid.

“This isn’t enough. But it says something about a medical system that fails to recognize the pain of many Lyme disease patients and their inability to get good care.”

Court filings

Here is background on the case from the latest court document. [Comments in brackets have been added for clarity.]

Plaintiffs sued Defendant in November 2017. Docket No. 1. Since filing their Original Complaint, Plaintiffs have maintained the allegation that Defendant [the Infectious Diseases Society of America], the Doctors [the authors of the IDSA Lyme guidelines] and the Insurance Defendants [eight insurance companies named in the original suit] have engaged in a decades-long conspiracy to deny the existence and prevent treatment of chronic Lyme disease.

Plaintiffs alleged that doctors have known for a long time that while many patients who contract Lyme disease may be cured with short-term antibiotics, up to 40 percent of patients do not respond to short-term antibiotic treatment.  

These patients require long-term antibiotic treatment until the symptoms are resolved. Though the Insurance Defendants initially provided coverage for long-term antibiotic treatment of Lyme disease, the health insurance industry made a concerted effort in the 1990’s to deny coverage because long-term treatment was too expensive. 

The Insurance Defendants enlisted the help of doctors who were researching Lyme disease—the IDSA panelists—and paid them large fees to develop arbitrary guidelines for testing Lyme disease. 

Once these guidelines were established, the Insurance Defendants denied coverage for patients who did not meet the new stringent Lyme disease testing protocols and prevented Plaintiffs from obtaining the antibiotics needed to treat their Lyme disease.

Click here to read the rest of this document.

The IDSA had also asked the court to impose legal sanctions (penalties) against the patients who brought the lawsuit. The court refused to do that.

Mary Beth Pfeiffer, author of “Lyme: The First Epidemic of Climate Change,” maintains a website with information about this lawsuit. Click here to see court filings and other history of this case.

Online Premiere of New Lyme Film

https://www.lymedisease.org/your-labs-are-normal-premiere/

Online premiere of new Lyme film Wednesday, October 20

October 17 update: The premiere originally scheduled for October 20 has been postponed. According to Rhisa Marie Perera, she did not anticipate so much attention, both locally, and worldwide. She has been advised to push back the date to pursue further options for distribution. When the new date is chosen, we’ll let you know about it.

From Rhisa Marie Parera, Lyme patient and filmmaker:

At 17, I collapsed on my senior trip in high school and spent months in and out of doctors’ offices. After a brief period of respite, I was 19 years old when the intense migraines and constant dizzy spells began. Then, in my early to mid-twenties, constant joint and muscle pain.

Add all of this to a part-time job and full college workload, and I felt like I was running on fumes. I couldn’t believe this was my life. By the time I was 29, I could barely function. After seeing dozens of doctors in my twenties, I was finally diagnosed with Lyme disease.

There were absolutely no answers or help from medical professionals. I had to figure it out on my own to start healing. As a kid, all I ever wanted to do was write stories. I dreamed of writing for a television show, movies, Broadway, anything! I ended up thinking, Why not write down my own story? Six months into the COVID-19 quarantine, I started writing and knocked out a few drafts….

******

Those drafts turned into a film called  YOUR LABS ARE NORMAL. Its online premiere will be October 20. Viewing it will be freely available to anybody. The link to the film will be posted on Rhisa’s Facebook page on Wednesday.

Click below to watch a trailer of film:

Previous blog by Rhisa:

10 years of headaches, vertigo and other pains dismissed as “depression”

______________

For more:

Head Trauma, Prolonged Neurological Symptoms, & Lyme Disease

https://www.lymedisease.org/head-trauma-lyme-disease/

Head trauma, prolonged neurological symptoms, and Lyme disease

By Daniel A. Kinderlehrer MD

When Brian finished college, he had dreams of becoming a professional hockey player. Unfortunately, he got a rough blow to the head and sustained a concussion. Although he didn’t lose consciousness, he developed a host of symptoms that led to leaving the ice.

He complained of daily headaches that were worse with exertion, physical and mental fatigue, decreased concentration and short-term memory, joint pains, muscle pains, muscle cramps, chest pain, sore soles that were more tender when first getting out of bed, paresthesias (pins and needles sensations) in his fingers and toes; daytime sweats and urethritis—pain on urination.

Sound familiar? Brian had spent time in upstate New York and went to college in Massachusetts. He had never seen a tick attachment nor an EM rash. An alert physician ran a Lyme Western Blot test but the only positive band was the IgG 18 kd, which was interpreted as negative.

The plot thickens

Because of his ongoing urethritis, Brian was put on Cipro for one week and all his symptoms flared. Later he was prescribed Levaquin, but he suffered the same reaction and stopped it after two days

Brian got checked out by specialists at a highly regarded medical center, but they could shed no light on the matter.

Brian’s symptoms were getting worse, including a sore throat with swollen glands. He had another Lyme Western Blot (performed at Labcorp) in which the IgM was now reactive at 23 kd. This was interpreted as positive for Lyme disease.

He was then prescribed doxycycline 100 mg twice daily. He herxed for five days and over the next two months he experienced mild improvement.

Post-Concussive Syndrome

I’m going to take a break from Brian to discuss post-concussive syndrome (PCS), symptoms that persist after a traumatic brain injury (TBI). The symptoms of PCS include headache, dizziness, neck pain, exercise intolerance, irritability, anxiety, sleep problems, diminished cognition with memory loss, poor concentration and difficulty with problem-solving, noise and light sensitivity.

In 2019, Sergio Azzolino and colleagues published a report entitled “The prevalence of Lyme disease and associated co-infections in people with a chronic post-concussive syndrome.”1 They wondered if patients with TBIs who continued to have symptoms of post-concussive syndrome a year after their head trauma had undiagnosed Lyme disease.

They did a retrospective chart review of patients who fit the criteria of ongoing symptoms of PCS at least a year after suffering a TBI. To be included in the study, patients had to have a negative brain computed tomography (CT) or magnetic resonance imaging (MRI) scan. Participants were excluded from the study if they had previously tested positive for Lyme and/or co-infections; had two weeks of antibiotics since the date of injury; had been diagnosed with a primary neurological illness (e.g., seizure disorder or multiple sclerosis), or had post-stroke syndrome.

The researchers tested 69 patients who met those criteria: 38% had a positive IgM Western Blot and 26% had a positive Western Blot IgG. They also tested 18 patients without a history of TBI but who had symptoms consistent with PCS: 72% had a positive IgM Western Blot and 33% had a positive IgG Western Blot.

IgM in Lyme disease is not only acute infection

The IgM antibody is considered an acute phase reactant—acute in medicine means recent onset. In most infections, the IgM antibody to a pathogen starts rising soon after the onset of infection. Then begins its decline about a month later, when IgG–the chronic phase reactant–starts increasing. Usually, the IgM becomes negative and the IgG remains elevated while the infection is still active, but IgG can remain elevated long after the infection has been eradicated.

However, this is not the case with Lyme disease. In Lyme, the IgM does indeed rise early—it is usually detectable within one to two weeks. But if the infection is untreated, the elevation in IgM will persist.2,3 This may be due to changes in outer surface proteins on the bacteria that continually signal a new infection to our immune systems.

In the series by Azzolino et al., IgM positivity was disproportionately higher than IgG.  And the same was true in the group of people who had the neurological symptoms of PCS without a history of TBI.

Most of my patients present with chronic persistent Lyme disease that has not been previously treated—they have been ill for years or even decades. The vast majority have Western Blot IgM positivity disproportionate to IgG positivity. It is not unusual for these patients to be told that the positive IgM is a false positive, since they have been ill for a long time and do not have an acute infection.

Prolonged neurological symptoms after TBI may be caused by Lyme disease

It turns out that a significant number of folks who get banged in the head and develop prolonged neurological symptoms were already suffering from a dormant infection with Borrelia burgdorferi, the Lyme pathogen. We know that some people get a tick attachment but don’t see a rash and don’t experience acute Lyme disease—but weeks, months or years later they become ill with chronic Lyme disease.

Sometimes, the symptoms develop gradually, but often they develop almost overnight. In the latter situation, there is usually a trigger—a viral infection, mold exposure, taking an agent that suppresses the immune system like corticosteroids, a vaccine, emotional stress, and trauma of any kind—especially head trauma.

Dr. Chad Prusmack is a neurosurgeon in Denver who sees a lot of patients with head trauma. He is unique among neurosurgeons in that he also diagnoses and treats Lyme disease. Chad told me that in his clinical experience, a third of his patients with PCS have Lyme disease and improve with appropriate treatment.

He also notes that most of these patients have issues with mold sensitivity and mold toxins, as well as dysautonomia, especially POTS—Postural Orthostatic Tachycardia Syndrome–and they improve considerably when they are stabilized.

Back to Brian

When I initially saw Brian, I told him I didn’t know how much his neurological symptoms were still attributable to the TBI he sustained over a year earlier as opposed to symptoms caused by the tick-borne diseases.

I suspect many readers of Lymedisease.org have already surmised that Brian was suffering from both Lyme disease and bartonellosis. Morning pain on the soles of the feet, urethritis, daytime sweats, and Herxheimer reactions to Cipro and Levaquin are big tip-offs.

The short story is that with treatment Brian experienced a 100% remission. He wisely decided not to pursue a professional career on the ice, but instead went to medical school. At the time of this writing, he is completing an orthopedic residency.

When Brian was a fourth-year medical student, I asked him what attending physicians on the wards had to say about Lyme disease. His reply: “They think it’s a joke, it’s not real.” This level of denial among mainstream physicians is, distressingly, still quite common.

I talked with Dr. Azzolino recently. He told me his clinical experience has been similar to that of Dr. Prusmack, who found that treating his long-term PCS patients for their tick-borne infections “…resulted in a dramatic improvement in function and reduction in disability” in this patient population.

The bottom line is that head trauma can activate dormant infections that manifest with chronic neurological symptoms that overlap with those of PCS. Anyone with head trauma with persistent PCS should get checked for Lyme disease.

Dr. Daniel Kinderlehrer is an internal medicine physician with a private practice in Denver, Colorado, devoted to treating patients with tick-borne illness. He is the author of  Recovery From Lyme Disease: The Integrative Medicine Guide to the Diagnosis and Treatment of Tick-Borne Illness.

References

  1. Azzolino S, Zaman R, Hankir A, Carrick FR. The prevalence of Lyme disease and associated co-infections in people with a chronic post-concussive syndrome. Psychiatr Danub. 2019 Sep;31(Suppl 3):299-307. PMID: 31488744.
  2. Craft JE, Fischer DK, Shimamoto GT, Steere AC. Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness. J Clin Invest. 1986;78(4):934–939.
  3. Steere AC, et al. Lyme arthritis: correlation of serum and cryoglobulin IgM with activity, and serum IgG with remission. Arthritis Rheum.1979;22(5):471-83

For more:

Better Diagnostic Teesting: Antibodies & Beyond

https://www.lookingatlyme.ca/2021/10/40-better-diagnostic-testing-antibodies-and-beyond-with-dr-armin-schwarzbach/  Webinar Here

40. Better diagnostic testing: antibodies and beyond with Dr. Armin Schwarzbach

Detecting Lyme disease and related infections.

Episode 40 with Dr. Armin Scharwzbach from Armin Labs in Augsburg Germany.

In this episode of Looking at Lyme, we go to Augsburg, Germany to learn about diagnostic testing with Dr. Armin Schwarzbach, MD, PhD.

Dr. Schwarzbach is a specialist in laboratory medicine and infectious diseases, having worked in the field for over 20 years. He recalls one of his patients who was diagnosed with Multiple Sclerosis and tested positive for a test that was then called a lymphocyte transformation test for Borrelia burgdorferi even though she subsequently tested negative for antibodies to the bacteria. The patient had not responded to previous treatment for her MS (with steroids) but recovered after being treated for Lyme disease.

“[The Western Blot] is a screening test for transmission of Borrelia burgdorferi but not an activity test…I never have seen such cases where there are no antibodies, but cellular immune reactions.”

Dr. Armin Schwarzbach

Testing options

After recognizing that routine antibody tests for Lyme disease were unreliable, Dr. Schwarzbach decided to explore other methods of cellular analytics for patients with tick-borne illnesses based on cellular immune reactions. Although these tests are now performed in some other labs in Germany, Dr. Schwarzbach points out that many countries, including Canada, are not currently offering these types of tests. Canadian patients currently have to arrange to have their blood samples shipped to Germany to access the tests done at his laboratory.

“When I travelled around and people contacted me [I found that] nobody is doing the test in Canada, (or in many other countries).”

Dr. Armin Schwarzbach

B cells and T cells

Dr. Schwarzbach describes the difference between direct and indirect testing. Direct testing, including cultures and PCR (polymerase chain reaction) tests, look for direct evidence of a pathogen. Indirect testing, including antibody and t-cell tests, look at the body’s immune response to a pathogen. He differentiates between B cells, or antibodies in the form of proteins, and T-cells which are living cells called lymphocytes. Dr. Schwarzbach points out that in the US, the Centre for Disease Control (CDC) actually prefers a T-cell test for tuberculosis, but does not yet accept this test for Lyme disease.

 “B cells are the antibodies and the T cells are the lymphocytes. Antibodies are proteins, lymphocytes are living cells…in the whole diagnostic world I think (T cells) are underrepresented.”

Dr. Armin Schwarzbach

Antibody anomalies with Lyme disease

Dr. Schwarzbach also explains one of the other anomalies seen in Lyme disease patients. With other infections, IgM antibodies are normally produced early in the infectious process and IgG antibodies in the long term. In Lyme disease, they are observing the persistence of IgM antibodies but not IgG antibodies. He collaborated with professor Dr. Leona Gilbert, who was leading research on multiple tick borne diseases as well as persister forms and intracellular forms of Borrelia burgdorferi, sometimes called round bodies, cysts, or L-forms. Dr. Leona Gilbert discussed her research with Sarah in Season One of Looking at Lyme.

Testing for multiple infections

This research led to the creation of a test panel called the TickPlex, which includes various co-infections and opportunistic infections. Dr. Schwarzbach notes that a patient can test positive for multiple infections even if they test negative for Lyme disease. He explains that co-infections (also called tick-borne or vector-borne infections) are caused by pathogens found in vectors such as ticks, whereas opportunistic infections are already in our bodies and are normally kept under control by our immune system. When our immune system is not functioning properly, these opportunistic infections can re-activate, creating further health issues for patients with tick-borne infections such as Lyme disease.

“The TickPlex was developed because…we saw together with professor Gilbert that there are persister forms…we said why should we not test for these persister form antibodies…and that was a breakthrough because we found around 98% now with a persister form of antibodies.”

Dr. Armin Schwarzbach

The three “I’s” of infection

Dr. Schwarzbach explains that one of the biggest roadblocks to better testing is that many authorities don’t accept the concept of chronic infection. He hopes this will improve with the increased use of other testing modalities such as the TickPlex test. He discusses diagnostics for infections using the three “I’s”;  IgA, IgG and IgM antibodies, immune dysfunction tests, and inflammatory markers. Another test for Borrelia burgdorferi and SARS-CoV-2 is the I-spot, which can test both for past and current infection, and biopsy or tissue testing.  Dr. Schwarzbach points out that all of these tests are helpful not only for initial diagnosis, but also for monitoring patient progress and treatment effectiveness. He also notes that test results need to be considered in conjunction with what is happening clinically with patients, and with what patients are experiencing.

“What I see in this model with the three ‘I’s’ with SARS CoV-2, we diagnose it with antibodies, IgG, IgA…the second ‘I’ is the immune dysfunction…and the (third) ‘I’…is inflammation, the inflammatory markers…(we can) help therapists and to give additional information about infection, inflammation and immune dysfunction.”

Dr. Armin Schwarzbach

The COVID connection

What do Lyme disease, COVID and HIV infections have in common? They all can all cause reactivation of dormant infections in our bodies such as Epstein-Barr, Herpes Simplex, Coxsackie and Cytomegaloviruses as well as imbalances in yeast, mold and gut bacteria. In fact, in a recent study, 66.7% of long COVID patients were found to have reactivation of Epstein-Barr Virus. Dr. Schwarzbach points out that these patients may have other opportunistic infections which require diagnostic testing. He even developed a checklist to help clinicians determine which opportunistic infections may be active in their patients.

“I accept chronic infections… but the majority of doctors don’t accept this. They say yes you can have a current or recent infection… but it cannot get chronic. This is the struggle we have politically… I’m fighting for the acceptance of chronic infection, and this we can do by these wonderful blood tests.”

Dr. Armin Schwarzbach

New directions in testing

Looking to the future, Dr. Schwarzbach hopes to develop tests for biofilms, parasitic infections, gut viruses and bacteria, as well as yeast and mold. Thank you Dr. Schwarzbach for filling us in on the latest testing for infections that can be associated with Lyme disease! Remember to keep an eye out for ticks even as the weather gets cooler, and stay safe in the outdoors!

Resources

“(With the TickPlex test) we found also that all of these patients had multiple infections, so called co-infections from tick bites or re-activated infections, we name opportunistic infections; viruses and so on…so (Dr. Gilbert) designed a panel for that.”

For more: